Close to one lakh children below the age of five years died of diarrhoea attributable to rotavirus infection in India in 2008, accounting for 22 per cent of the total deaths reported globally that year, the latest edition of the Lancet Infectious Diseases magazine has reported. Worldwide in 2008, diarrhoea related to rotavirus infection resulted in 4,53,000 deaths in children younger than 5 years — 37 per cent of deaths attributable...
More »SEARCH RESULT
India leads in rotavirus infection deaths: Lancet by Aarti Dhar
Close to one lakh children below the age of five years died of diarrhoea attributable to rotavirus infection in 2008, accounting for 22 per cent of the total deaths reported globally, reports the latest edition of the Lancet Infection Diseases magazine. Diarrhoea related with the rotavirus infection resulted in 453,000 deaths worldwide in 2008 among children younger than five years—37 per cent of deaths attributable to diarrhoea with five countries accounting...
More »GM crops have not lived up to their promises, say NGOs by John Vidal
Genetic engineering has failed to increase the yield of any food crop but has vastly increased the use of chemicals and the growth of “superweeds,” according to a report by 20 Indian, southeast Asian, African and Latin American food and conservation groups representing millions of people. The so-called miracle crops, which were first sold in the U.S. about 20 years ago and which are now grown in 29 countries on about...
More »The Inconvenient Truth Of Soni Sori by Shoma Chaudhury
Why were two tribals and the Essar group framed by the Chhattisgarh police? Why are Soni Sori and Linga Kodopi being systematically silenced? This chilling story of one family reveals more about India's Naxal crisis than any official document can. AS I sit to write this, at 12.20 pm on 4 October 2011, an SMS pops up on my phone: “Soni Sori has been arrested by the Delhi Crime Branch.” The...
More »Medicines: For Saving Life or For Superprofits? by Bharat Dogra
Will patent rights be used only for ensuring the legitimate interests of pharmaceutical companies, or will these be used in an exaggerated and unjust way to deprive patients of their right to life? This crucial question, which has been debated time and again in the context of the significant case of Glivec, an anti-cancer drug, has now reached a critical stage. It may be pointed out here that as early as...
More »